Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting

Sarah Sharman Moser,1 Lior Apter,1,2 Idit Livnat,3 Roni Ginsburg,3 Adva Yarden,3 Michal Drori,1 Anat Drizon,1 Gabriel Chodick,1,4 Nava Siegelmann-Danieli1,4 1Maccabi Institute for Research and Innovation (Maccabitech), Maccabi Healthcare Services, Tel Aviv, Israel; 2Department of Health Systems Mana...

Full description

Bibliographic Details
Main Authors: Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Breast Cancer: Targets and Therapy
Subjects:
her2 positive
metastatic
breast cancer
observational study
real-world
Online Access:https://www.dovepress.com/clinical-outcomes-of-patients-with-her2-positive-metastatic-breast-can-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/clinical-outcomes-of-patients-with-her2-positive-metastatic-breast-can-peer-reviewed-fulltext-article-BCTT

Similar Items